One of the grand challenges in kinase drug discovery is the design of small-molecule inhibitors with selectivity profiles that will ultimately be efficacious in the clinic.
Identification of neutral ligands for the primary specificity pocket was a key discovery; capitalised upon by structure based design and combinatorial methods to deliver many variations on the theme; but it was good medicinal chemistry practice, in the optimisation of physical properties, which ultimately delivered efficacious compounds with adequate oral exposure.
Adaptive radiotherapy, where the dose distribution is altered during the treatment schedule to account for changes in patient anatomy, tumour volume or areas of tumour that respond later in the course of treatment, may be used to provide more personalised and, ultimately, more efficacious treatment for each individual patient [40].
The developed mineralized tumor models may help to reveal the underlying cellular and molecular mechanisms that may ultimately enable more efficacious therapy of patients with advanced breast cancer.
Our study demonstrates that that therapeutic targeting of IL-6/Stat3 signalling and/or B-lymphocytes may ultimately afford more efficacious treatments for IPF and related diseases than those directed solely against TGF-β/Smad3 signalling.
Ultimately, the development of efficacious therapeutic interventions will likely need to consider host pathogen interactions to enhance host immunity and circumvent bacterial evasion strategies.
Given that both are "first generation" T cell redirecting, fully mouse antibodies for very different indications, it is difficult to say today which type of platform (fragment vs. IgG-based) will ultimately be the most efficacious for treatment of diseases.
These findings provide new insights into the rational engineering of VLP vaccines, and could ultimately enable safe and efficacious vaccine design as an alternative to conventional approaches necessitating pathogen cultivation.
As with anti-Aβ immunotherapies, it is likely that a better understanding of the mechanism will ultimately result in more efficacious and safer immunotherapy.
Such a reality means that the number of enrollees needs to be very large (thousands) in order to achieve statistical significance for a drug that is ultimately shown to be efficacious.
